A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure
Atherosclerosis, myocardial infarction (MI) and heart failure (HF) are the main causes of mortality and morbidity around the globe. New therapies are needed to better manage ischemic heart disease and HF as existing strategies are not curative. Resveratrol is a stilbene polyphenolic compound with fa...
Guardado en:
Autores principales: | Pema Raj, Sijo Joseph Thandapilly, Jeffrey Wigle, Shelley Zieroth, Thomas Netticadan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/407e793447334e0db2b1de53351ea51b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Innate Lymphoid Cells and Myocardial Infarction
por: Wenling Yang, et al.
Publicado: (2021) -
Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without Diabetes
por: Viveca Ritsinger, et al.
Publicado: (2021) -
The effect of empagliflozin on the development of chronic heart failure after myocardial infarction according to a 12-month prospective study
por: Alexey A. Nekrasov, et al.
Publicado: (2019) -
Long-Term Pharmacological Management of Reduced Ejection Fraction Following Acute Myocardial Infarction: Current Status and Future Prospects
por: Abel AAI, et al.
Publicado: (2021) -
Examining Predictors of Myocardial Infarction
por: Diane Dolezel, et al.
Publicado: (2021)